5% and 20%. 12, 13 Ideally, a preoperative evaluation should identify those children who will require permanent CSF diversion after tumor resection so that the treatment could be tailored to the individual child. Therefore, the CPPRH was developed in an effort to stratify patients according to their risk of developing postoperative hydrocephalus after the resection of a posterior fossa tumor. 16 In this study, we sought to externally validate the CPPRH model for the prediction of postoperative hydrocephalus following posterior fossa tumor resection in pediatric patients and to address potential shortcomings of the current scoring system when preoperative funduscopic examinations are not available.
Methods
After approval by the internal review board, we conducted a retrospective chart review of 99 consecutive pediatric patients younger than or equal to 17 years of age who presented to the CHA from August of 2002 to October of 2010 with newly diagnosed, radiographically confirmed posterior fossa neoplasms and who subsequently underwent resection. None of the children eligible for this study underwent preresection permanent CSF diversion (CSF shunt insertion or ETV), and patients with preexisting unrelated hydrocephalus or without available preoperative imaging were excluded. The majority of patients without available preoperative imaging were treated before the development of a digital imaging library at the CHA, and the hard copies of the images were no longer available at the time of this study. In addition, children who died within 6 months of tumor resection were also excluded.
Clinical and radiographic data were obtained by a chart review conducted by 2 physicians specializing in neurosurgery. Radiographic variables were obtained from MR images and CT scans in conjunction with reports performed by attending neuroradiologists.
In accordance with the original study by Riva-Cambrin et al., 16 age at tumor diagnosis was used to dichotomize the patients into 2 groups, children 2 years of age or older and children younger than 2 years. Preoperative lethargy was defined as lethargy, drowsiness, decreased alertness, unresponsiveness, or a Glasgow Coma Scale score of less than 14 documented on admission. The duration of the signs or symptoms of raised intracranial pressure was obtained from admission histories. Papilledema was defined as a preoperative determination of optic nerve edema by the neurosurgeon or ophthalmologist, as recorded in the patient's chart. The degree of hydrocephalus was recorded qualitatively as none, mild, moderate, or severe as noted on the imaging report. This variable was dichotomized into none/mild and moderate/severe categories in order to minimize the subjective nature of a qualitative predictor. In addition, the presence of transependymal edema was recorded and defined as periventricular hypodensity on CT scans, increased periventricular T2 signal on FLAIR MR images, or both. Tumor size was measured as the largest diameter of the tumor on any single axial slice of preoperative imaging. Tumor hemorrhage was defined as intraor peritumoral hemorrhage on admission imaging. Intracranial metastases included both diffuse leptomeningeal spread and secondary solid disease. Tumor location was measured as the distance between the geometrical center (intersection of the 2 largest diameters) of the tumor and the midline. Predicted tumor pathology was defined as the attending neuroradiologists' prediction of tumor histology based solely on the tumor's preoperative radiological characteristics. The primary outcome measure was hydrocephalus within 6 months of tumor diagnosis, as defined by the occurrence of either ventricular shunting or ETV. Clinical and radiographic data, as well as the occurrence of the primary end point, were compared with the original derivation cohort (Toronto) and the original validation cohort (Vancouver).
The CPPRH identifies 5 clinical characteristics (age < 2 years, presence of papilledema, moderate/severe hydrocephalus, cerebral metastases, and preoperative tumor diagnosis) and assigns numerical values between 1 and 3 with a total possible score of 10. The greater the score, the greater the risk of postoperative hydrocephalus, with probabilities ranging from 0.071 with a score of 0 to 0.956 with a score of 10. Scores were then dichotomized into low risk (0-4) and high risk (5-10), with observed likelihood ratios of 0.714 and 6.098 respectively. 16 The modified mCPPRH also utilizes 5 clinical characteristics (age < 2 years, presence of transependymal edema, moderate/severe hydrocephalus, cerebral metastases, and preoperative tumor diagnosis) and assigns numerical values between 1 and 3 with a total possible score of 10. Transependymal edema was identified as a variable to replace papilledema in the score because preoperative retinal examinations were not performed on the majority of our cohort. As in the original model, the greater the score, the greater the risk of postoperative hydrocephalus requiring permanent CSF diversion.
Statistical Analysis
To assess the statistical significance of differences, clinical and radiological potential predictors from the CHA study cohort were compared separately with the Toronto (TOR) and Vancouver (VAN) cohorts using chi-square (or Fisher exact test if assumptions for the chi-square test were not met) and Student t-tests where appropriate. Logistic regression models were constructed to identify independent associations with hydrocephalus within 6 months of tumor diagnosis. As in the original multivariate model by Riva-Cambrin et al., 16 the referent category for a radiologist's estimation of diagnosis in the logistic model was juvenile pilocytic astrocytoma. All 5 clinical characteristics identified in the mCPPRH were retained in the multivariate model. The discrimination ability of the model was assessed by means of an ROC curve. Measures of association are presented as adjusted odds ratios with 95% confidence intervals. Statistical analyses were performed using SAS version 9.3 (SAS Institute).
Results

Patient Population
Clinical and radiographic data of 99 consecutive patients were reviewed. These patients were younger than or equal to 17 years of age, presented to the CHA between 2002 and 2010 with posterior fossa tumors, and subsequently underwent resection. Twenty-three patients were excluded from the analysis: 20 because of a lack of available preoperative imaging and 3 because they had died before the 6-month postoperative follow-up. The remaining 76 patients were analyzed using the CPPRH. The mean age of the patients was 92 months, 51% were male, and 75% presented with some degree of hydrocephalus. When the CHA study population was compared with the TOR derivation cohort and the VAN original validation cohort, the populations were similar with the exception of mean duration of symptoms (CHA 6.6 weeks vs TOR 18.2 weeks, p < 0.001; and CHA 6.6 weeks vs VAN 21.7 weeks, p = 0.002), presence of papilledema (CHA present in 5.1%, absent in 7.1%, not noted in 87.9% vs TOR present in 63.3%, absent in 25.4%, not noted in 11.4%; p < 0.001; and CHA vs VAN present in 55%, absent in 31.5%, not noted in 13.5%; p < 0.001), degree of hydrocephalus (CHA vs TOR p < 0.001 and CHA vs VAN p = 0.02), and mean tumor size (CHA 41.2 vs TOR 44.8 mm, p = 0.003, and CHA 41.2 vs VAN 46.8 mm, p = 0.04). Permanent CSF diversion at 6 months was performed in 21.1% of patients of the CHA cohort, 31.2% (p = 0.08) of the TOR, and 18.9% (p = 0.7) of the VAN cohorts. The baseline characteristics of the 3 cohorts are detailed in Table 1 .
Papilledema Versus Transependymal Edema
The observation of the presence or absence of papilledema differed significantly when the CHA cohort was compared with the TOR (p < 0.001) and VAN (p < 0.001) cohorts. In nearly 88% of the CHA cohort, the presence or absence of papilledema was not noted; in contrast, papilledema presence or absence was not noted in only 11% of the TOR and 13% of the VAN cohorts. This is a result of the difficulty in obtaining reliable visualization of the optic disc in a young child and of an institutional culture that did not routinely conduct ophthalmology consultations in children presenting with posterior fossa tumors and hydrocephalus. Given this large discrepancy and our relative lack of data for this variable, transependymal edema was used as a substitute for papilledema in our model. The prevalence of transependymal edema on preoperative MRI was remarkably similar across the 3 centers, with a 60.5% prevalence in the CHA, 57.1% in the TOR (p = 0.6), and 57.4% in the VAN (p = 0.7) cohorts.
Bivariate and Multivariate Analysis
Bivariate and multivariate analyses were performed comparing the 60 patients not requiring permanent CSF diversion to the 16 patients requiring permanent CSF diversion. Four factors were found to be statistically significant in the bivariate analysis; these included age younger than 2 years (p = 0.05), degree of hydrocephalus (p = 0.007), radiologist's estimation of diagnosis (p = 0.025), and transependymal edema (p = 0.01). The multivariate analysis indicated only the radiologist's estimation of diagnosis of ependymoma as significant (p = 0.05). These findings were comparable to the original results from the TOR cohort whose bivariate analysis indicated statistically significant effects of age younger than 2 years, mean duration of symptoms (patients with a longer duration of symptoms being more likely to require permanent CSF diversion), presence of papilledema, lethargy on presentation, moderate/severe hydrocephalus, mean tumor location (patients with tumors closer to the midline are more likely to require permanent CSF diversion), and CSF metastases; the multivariate analysis of the TOR cohort also indicated significant effects for age younger than 2 years, presence of papilledema, moderate/severe hydrocephalus, CSF metastases, and radiologist's estimation of tumor diagnosis. The results of the bivariate and multivariate analyses for the CHA cohort are shown in Table 2 .
Application of the Modified CPPRH
The mCPPRH utilizes 5 variables (age younger than 2 years, presence of transependymal edema, moderate/severe hydrocephalus, cerebral metastases, and preoperative estimated tumor diagnosis) for a total possible score of 10. The greater this score, the greater the likelihood of a requirement for permanent CSF diversion within 6 months of a posterior fossa tumor resection. Table 3 shows the results of this scoring method. An area under the ROC curve of 0.816 was calculated for the mCPPRH.
Observed likelihood ratios of patients with a score dichotomized into low risk (0-4) and high risk (5-10) were 0.737 (95% CI 0.526-1.032) and 4.688 (95% CI 1.421-15.463), respectively. These compared favorably with the likelihood ratios in low-risk strata of 0.714 and 0.829 and the likelihood ratios of high-risk strata 6.098 and 2.958 in TOR and VAN, respectively, which used the original CPPRH using papilledema as a variable. Table 4 shows the observed likelihood ratios of the CHA, TOR, and VAN cohorts.
After stratifying patients into low-(0-4) and highrisk (5-10) groups for the dichotomous event of shunting or no shunting, the discordance was 19.7. Table 5 shows the mCPPRH scores for the CHA cohort.
Discussion
Hydrocephalus is a well-recognized confounder in the treatment of posterior fossa tumors. Although it is clear that there are aberrant preoperative CSF flow dynamics, it is unknown which patients will require permanent CSF diversion after resection of these tumors. Given this uncertainty, Riva-Cambrin et al. introduced the CPPRH in an effort to identify preoperative factors that would predict the need for permanent CSF diversion following the resection of a posterior fossa tumors. 16 Our study sought to externally validate and modify this model. Individual risk factors including young age, 16 symptom duration, 8 insertion of an external ventricular drain, 8 and postoperative pseudomeningocele or meningitis 8 have been reported to be associated with the need for permanent postoperative CSF diversion. Our study supports the assertion that young age, degree of hydrocephalus, and radiologist's preoperative tumor diagnosis are associated with postoperative hydrocephalus, and it also presents the novel predictor of transependymal edema.
In the study by Riva-Cambrin et al. introducing the CPPRH, the authors note that, despite the variable "presence of papilledema" having a multivariate OR of 2.59, they elected to modify the score in the model to 1 because the data quality was weakened by incomplete data from 11% of their patients. 16 In our study, 88% of the patients had incomplete data for this variable, significantly weakening its predictive value in a retrospective study. The lack of data for the prevalence of papilledema is a result of the difficulty in obtaining reliable visualization of the optic disc in young children and of an institutional bias for not obtaining routine preoperative ophthalmology consultations from children presenting with posterior fossa tumors over the interval of the study. Even though papilledema has been reported as a highly specific marker for elevated intracranial pressure, the sensitivity for detecting papilledema is only 22% in those younger than 8 years of age. 22 Tuite et al. hypothesized that this age-dependent sensitivity may reflect the presence of unfused sutures, 23 the fact that the subarachnoid space surrounding the optic nerve may not communicate with the subarachnoid space surrounding the brain, or the difficulty of conducting an ophthalmological exam in younger children.
22
Transependymal edema, also known as periventricular edema, is a well-established marker of increased intracranial pressure associated with obstructive hydrocephalus. 11, 24 Its ease of identification on routine imaging modalities lends to the use of transependymal edema in a predictive model. Bivariate analysis revealed a statistically significant association between the presence of transependymal edema and permanent CSF diversion at 6 months. Given these findings, transependymal edema was substituted for papilledema in the predictive model for hydrocephalus.
The CPPRH has previously been shown to be an accurate predictor for hydrocephalus as evidenced by the * Radiological characteristics are based on only 76, 331, and 108 patients in the CHA, TOR, and VAN cohorts, respectively, because preoperative imaging was unavailable in the other patients. † Patients for whom preoperative imaging was available. ‡ Tumor location was measured as the distance between the geometrical center (intersection of the 2 largest diameters) of the tumor and the midline.
area under the ROC curves of 0.762 and 0.643 in the TOR (derivation) and VAN (validation) cohorts. 16 Our study using the mCPPRH indicated an area under the curve of 0.816 for this model, demonstrating the accuracy of this method despite the substitution of transependymal edema for papilledema. The observed likelihood ratios of 0.737 and 4.688 derived from the mCPPRH in the lowand high-risk strata (Table 4) , respectively, are similar to those produced by the original CPPRH with the other 2 cohorts. As intended by the original model, our modified model seeks to identify those at greatest risk for developing postresection hydrocephalus. This can facilitate preoperative counseling of the patient and family, while allowing for tailored use of prophylactic endoscopic third ventriculostomies as proposed by Sainte-Rose et al. 18 if a treating surgeon so wishes.
Despite the significant difference in "degree of hydrocephalus" as assessed by preoperative imaging (CHA vs TOR, p < 0.0001 and CHA vs VAN, p = 0.02; Table 1), the model retained its predictive value, as evidenced by the areas under the ROC curve and the observed likelihood ratios among the 3 centers. This attests to the durability of the model in the face of a subjective interpretation of preoperative hydrocephalus, and, more importantly, this demonstrates accurate predictions in the face of a subjective primary outcome-hydrocephalus as defined by CSF diversion at 6 months postoperatively. The significant difference in the occurrence of the primary outcome was explored in Riva Cambrin et al.'s original publication, and a Bayesian adjustment further strengthened their external validation. 16 We did not observe statistically significant differences in the occurrence of the primary outcome of CSF diversion when comparing CHA vs TOR (p = 0.08) and CHA vs VAN (p = 0.7) ( Table 1) .
Limitations
This study has several limitations. As a retrospective chart review, it is subject to bias and confounders, and it is inherently reliant on previously recorded data. A relatively small patient population was used (n = 76) when compared with the size of the population in the derivation cohort reported by Riva-Cambrin et al. 16 (n = 331). This increases the chance of a Type II error, which results in failure to detect a statistically significant difference due to an underpowered study. The use of qualitative measures of hydrocephalus could be criticized as inaccurate. However, the ubiquity of this qualitative measure and the comfort it provides to most clinicians outweigh any small penalty to the score's accuracy.
Conclusions
While seeking to externally validate the CPPRH, a critical appraisal and modification of the original CPPRH model produced what we have coined the "Modified Canadian Preoperative Prediction Rule for Hydrocephalus." The mCPPRH utilizes easily obtainable and reliable preoperative variables that together stratify children with posterior fossa tumors into high-and low-risk categories for the development of postresection hydrocephalus. The mCPPRH may be used when there is no preoperative funduscopic exam available. This will aid patient counseling and tailor the intensity of postoperative clinical and radiographic monitoring for hydrocephalus, as well as provide evidence-based guidance for the use of prophylactic CSF diversion.
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